Eco R1 Capital, LLC Merus N.V. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$10.5 - $17.36 $18 Million - $29.8 Million	-1,715,962 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $25,378 - $43,506	-2,238 Reduced 0.13%	1,715,962 $20.8 Million
Q4 2019 Feb 14, 2020	BUY	$14.08 - $18.5 $21.9 Million - $28.7 Million	1,552,600 Added 937.56%	1,718,200 $24.2 Million
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.52 $2.41 Million - $3.4 Million	165,600 New	165,600 $2.95 Million

203

62M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.86B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.